{"id":17481,"date":"2021-01-28T18:37:06","date_gmt":"2021-01-28T17:37:06","guid":{"rendered":"https:\/\/genesis-biomed.com\/?page_id=17481"},"modified":"2025-06-16T15:23:35","modified_gmt":"2025-06-16T13:23:35","slug":"historias-de-exito","status":"publish","type":"page","link":"https:\/\/genesis-biomed.com\/es\/historias-de-exito\/","title":{"rendered":"Historias de \u00e9xito"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row css_animation=\u00bb\u00bb row_type=\u00bbrow\u00bb use_row_as_full_screen_section=\u00bbno\u00bb type=\u00bbgrid\u00bb angled_section=\u00bbno\u00bb text_align=\u00bbleft\u00bb background_image_as_pattern=\u00bbwithout_pattern\u00bb z_index=\u00bb\u00bb][vc_column][vc_empty_space height=\u00bb80&#8243;][vc_column_text]<\/p>\n<h3 style=\"text-align: center;\">Algunos de los casos de \u00e9xito en los que hemos trabajado<\/h3>\n<p>[\/vc_column_text][vc_empty_space height=\u00bb80&#8243;][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbfull_width\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb20307&#8243; img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Proyecto IVD:<\/strong> diagn\u00f3stico de enfermedad renal cr\u00f3nica<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac1M<\/strong> captados en julio de 2023<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> Fundaci\u00f3n Bot\u00edn Business Angels y Fondos de la UE<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb17298&#8243; alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Proyecto MedTech:<\/strong> estratificaci\u00f3n de pacientes que padecen fibrilaci\u00f3n auricular<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac2,35M<\/strong> captados en Julio de 2021<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> Clave Capital, Family offices y crowdfunding<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb17296&#8243; alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Proyecto farmac\u00e9utico: <\/strong> tratamiento de la infertilidad femenina<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac5M<\/strong> captados en mayo de 2020<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> Inveready, CDTI, Capital Cell, Family Offices<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb17299&#8243; alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Proyecto farmac\u00e9utico:<\/strong> nuevo apt\u00e1mero para accidente cerebrovascular isqu\u00e9mico<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac4.5M<\/strong> captados en mayo de 2017<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> Caixa Capital Risc e Inveready<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_empty_space height=\u00bb80&#8243;][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbfull_width\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb css=\u00bb.vc_custom_1611046965749{margin-right: 20px !important;margin-left: 20px !important;}\u00bb][vc_column_inner width=\u00bb1\/3&#8243;][vc_single_image image=\u00bb17301&#8243; img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Medtech project:<\/strong> nuevo cat\u00e9ter para trombectomia<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac15M<\/strong> captados en mayo de 2017<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> Ysios, Omega, Innogest y Banc Sabadell<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/3&#8243;][vc_single_image image=\u00bb17303&#8243; img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Proyecto Biotech:<\/strong> prote\u00edna recombinante para NSCLC y TNBC<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac4.2M<\/strong> captados en julio de 2017<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> ALTA Life Sciences y Healthequity<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][vc_column_inner width=\u00bb1\/3&#8243;][vc_single_image image=\u00bb17305&#8243; img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;]<\/p>\n<ul>\n<li style=\"text-align: center;\"><strong>Proyecto IVD:<\/strong> nuevo biomarcador de isquemia cardiovascular<\/li>\n<li style=\"text-align: center;\"><strong>\u20ac3.1M<\/strong> captados en octubre de 2017<\/li>\n<li style=\"text-align: center;\"><strong>Inversores:<\/strong> Caixa Capital Risc y Healthequity<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbfull_width\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner][vc_empty_space height=\u00bb50&#8243;][\/vc_column_inner][\/vc_row_inner][vc_column_text]<\/p>\n<h3 style=\"text-align: center;\">Listado completo de todas las rondas de inversi\u00f3n en las que hemos trabajado<\/h3>\n<p>[\/vc_column_text][vc_empty_space height=\u00bb30&#8243;][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbfull_width\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner][vc_column_text css=\u00bb\u00bb]<\/p>\n<table class=\" aligncenter\" style=\"text-align: left; width: 100%;\">\n<tbody>\n<tr style=\"background-color: #0070c0; color: #ffffff;\">\n<th style=\"height: 24px; width: 15%;\">Ofertas firmadas<\/th>\n<th style=\"height: 24px; width: 15%;\">Sector<\/th>\n<th style=\"height: 24px; width: 10%;\">Tama\u00f1o de la ronda<\/th>\n<th style=\"height: 24px; width: 10%;\">A\u00f1o<\/th>\n<th style=\"height: 24px; width: 40%;\">Inversores<\/th>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>AptaTargets<\/strong><\/td>\n<td style=\"height: 24px;\">Pharma<\/td>\n<td style=\"height: 24px;\">4.5 M\u20ac<\/td>\n<td style=\"height: 24px;\">2017<\/td>\n<td style=\"height: 24px;\">Caixa Capital Risc, Inveready<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>Anaconda Biomed<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">15 M\u20ac<\/td>\n<td style=\"height: 24px;\">2017<\/td>\n<td style=\"height: 24px;\">Ysios, Omega, Innogest, BSabadell<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>Peptomyc<\/strong><\/td>\n<td style=\"height: 24px;\">Biotech<\/td>\n<td style=\"height: 24px;\">4.2 M\u20ac<\/td>\n<td style=\"height: 24px;\">2017<\/td>\n<td style=\"height: 24px;\">ALTA Life Sciences, Healthequity<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>GlyCardial Diagnostics<\/strong><\/td>\n<td style=\"height: 24px;\">IVD<\/td>\n<td style=\"height: 24px;\">3.1 M\u20ac<\/td>\n<td style=\"height: 24px;\">2017<\/td>\n<td style=\"height: 24px;\">Caixa Capital Risc, Healthequity<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>MJN Neuroserveis<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">750 k\u20ac<\/td>\n<td style=\"height: 24px;\">2018<\/td>\n<td style=\"height: 24px;\">Ship2B and Family Offices<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>CORNEA Project<\/strong><\/td>\n<td style=\"height: 24px;\">IVD<\/td>\n<td style=\"height: 24px;\">300 k\u20ac<\/td>\n<td style=\"height: 24px;\">2018<\/td>\n<td style=\"height: 24px;\">Industrial partner<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>Corify Care<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">1 M\u20ac<\/td>\n<td style=\"height: 24px;\">2019<\/td>\n<td style=\"height: 24px;\">Family Office and EU Funds<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>Oxolife<\/strong><\/td>\n<td style=\"height: 24px;\">Pharma<\/td>\n<td style=\"height: 24px;\">300 k\u20ac<\/td>\n<td style=\"height: 24px;\">2019<\/td>\n<td style=\"height: 24px;\">Family Office<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>CORNEA Project<\/strong><\/td>\n<td style=\"height: 24px;\">IVD<\/td>\n<td style=\"height: 24px;\">300 k\u20ac<\/td>\n<td style=\"height: 24px;\">2019<\/td>\n<td style=\"height: 24px;\">Family Office<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>LiverScreen Project<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">8.5 M\u20ac<\/td>\n<td style=\"height: 24px;\">2019<\/td>\n<td style=\"height: 24px;\">EU Funds<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>CreatSens<\/strong><\/td>\n<td style=\"height: 24px;\">IVD<\/td>\n<td style=\"height: 24px;\">750 k\u20ac<\/td>\n<td style=\"height: 24px;\">2019<\/td>\n<td style=\"height: 24px;\">EU Funds<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>ABLE Human Motion<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">2.5 M\u20ac<\/td>\n<td style=\"height: 24px;\">2019<\/td>\n<td style=\"height: 24px;\">EU Funds<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>Peptomyc<\/strong><\/td>\n<td style=\"height: 24px;\">Pharma<\/td>\n<td style=\"height: 24px;\">11.4 M\u20ac<\/td>\n<td style=\"height: 24px;\">2020<\/td>\n<td style=\"height: 24px;\">AurorA Science, ALTA LS, Healthequity<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>Oxolife<\/strong><\/td>\n<td style=\"height: 24px;\">Pharma<\/td>\n<td style=\"height: 24px;\">5 M\u20ac<\/td>\n<td style=\"height: 24px;\">2020<\/td>\n<td style=\"height: 24px;\">Inveready, CDTI, crowdfunding<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>CORNEA Project<\/strong><\/td>\n<td style=\"height: 24px;\">IVD<\/td>\n<td style=\"height: 24px;\">1 M\u20ac<\/td>\n<td style=\"height: 24px;\">2020<\/td>\n<td style=\"height: 24px;\">Capital Cell and BAs<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>Corify Care<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">2.35 M\u20ac<\/td>\n<td style=\"height: 24px;\">2021<\/td>\n<td style=\"height: 24px;\">Clave Capital, CDTI, FOs and crowdfunding<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>Endolipid Therapeutics<\/strong><\/td>\n<td style=\"height: 24px;\">Dermocosmetic<\/td>\n<td style=\"height: 24px;\">500 k\u20ac<\/td>\n<td style=\"height: 24px;\">2021<\/td>\n<td style=\"height: 24px;\">Family offices, Business Angels, Crowdfunding<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>MOWOOT<\/strong><\/td>\n<td style=\"height: 24px;\">Medtech<\/td>\n<td style=\"height: 24px;\">1 M\u20ac<\/td>\n<td style=\"height: 24px;\">2022<\/td>\n<td style=\"height: 24px;\">Family offices, crowdfunding, ENISA<\/td>\n<\/tr>\n<tr style=\"height: 24px;\">\n<td style=\"height: 24px;\"><strong>Thytech<\/strong><\/td>\n<td style=\"height: 24px;\">Pharma<\/td>\n<td style=\"height: 24px;\">650 k\u20ac<\/td>\n<td style=\"height: 24px;\">2022<\/td>\n<td style=\"height: 24px;\">Family office and BAs<\/td>\n<\/tr>\n<tr style=\"background-color: #dedede;\">\n<td style=\"height: 24px;\"><strong>Renalyse<\/strong><\/td>\n<td style=\"height: 24px;\">IVD<\/td>\n<td style=\"height: 24px;\">1 M\u20ac<\/td>\n<td style=\"height: 24px;\">2023<\/td>\n<td style=\"height: 24px;\">Fundaci\u00f3n Bot\u00edn, Business Angels, EU Funds<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row css_animation=\u00bb\u00bb row_type=\u00bbrow\u00bb use_row_as_full_screen_section=\u00bbno\u00bb type=\u00bbfull_width\u00bb angled_section=\u00bbno\u00bb text_align=\u00bbleft\u00bb background_image_as_pattern=\u00bbwithout_pattern\u00bb][vc_column][vc_empty_space height=\u00bb100&#8243;][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row css_animation=\u00bb\u00bb row_type=\u00bbrow\u00bb use_row_as_full_screen_section=\u00bbno\u00bb type=\u00bbgrid\u00bb angled_section=\u00bbno\u00bb text_align=\u00bbleft\u00bb background_image_as_pattern=\u00bbwithout_pattern\u00bb z_index=\u00bb\u00bb][vc_column][vc_empty_space height=\u00bb80&#8243;][vc_column_text] Algunos de los casos de \u00e9xito en los que hemos trabajado [\/vc_column_text][vc_empty_space height=\u00bb80&#8243;][vc_row_inner row_type=\u00bbrow\u00bb type=\u00bbfull_width\u00bb text_align=\u00bbleft\u00bb css_animation=\u00bb\u00bb][vc_column_inner width=\u00bb1\/4&#8243;][vc_single_image image=\u00bb20307&#8243; img_size=\u00bbmedium\u00bb alignment=\u00bbcenter\u00bb qode_css_animation=\u00bb\u00bb][vc_column_text el_class=\u00bblist_02&#8243;] Proyecto IVD: diagn\u00f3stico de enfermedad renal cr\u00f3nica \u20ac1M captados en julio de&#8230;<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"full_width.php","meta":{"inline_featured_image":false,"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-17481","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/pages\/17481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/comments?post=17481"}],"version-history":[{"count":23,"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/pages\/17481\/revisions"}],"predecessor-version":[{"id":23130,"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/pages\/17481\/revisions\/23130"}],"wp:attachment":[{"href":"https:\/\/genesis-biomed.com\/es\/wp-json\/wp\/v2\/media?parent=17481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}